| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Amyotrophic Lateral Sclerosis | 8 | 2019 | 398 | 3.38 | Why? |
| Polydeoxyribonucleotides | 5 | 2019 | 118 | 3.36 | Why? |
| Myotonic Dystrophy | 5 | 2018 | 51 | 2.89 | Why? |
| Spinal Nerve Roots | 3 | 2018 | 8 | 2.20 | Why? |
| Injections, Epidural | 3 | 2018 | 45 | 2.19 | Why? |
| Neural Conduction | 6 | 2017 | 261 | 2.11 | Why? |
| Deglutition Disorders | 5 | 2019 | 481 | 2.06 | Why? |
| Benzothiazoles | 3 | 2018 | 128 | 1.99 | Why? |
| Shoulder Injuries | 2 | 2020 | 13 | 1.71 | Why? |
| Neck Muscles | 2 | 2018 | 18 | 1.48 | Why? |
| Reflex Sympathetic Dystrophy | 2 | 2018 | 2 | 1.45 | Why? |
| Cervical Vertebrae | 3 | 2018 | 151 | 1.44 | Why? |
| Phrenic Nerve | 2 | 2017 | 37 | 1.40 | Why? |
| Mental Status and Dementia Tests | 2 | 2019 | 208 | 1.40 | Why? |
| Pneumonia, Aspiration | 2 | 2018 | 69 | 1.40 | Why? |
| Ultrasonography, Doppler, Color | 2 | 2018 | 107 | 1.40 | Why? |
| Ultrasonography, Interventional | 5 | 2019 | 560 | 1.38 | Why? |
| Carpal Tunnel Syndrome | 2 | 2018 | 32 | 1.38 | Why? |
| Radiculopathy | 2 | 2018 | 79 | 1.37 | Why? |
| Reaction Time | 2 | 2017 | 96 | 1.35 | Why? |
| Electromyography | 5 | 2018 | 278 | 1.24 | Why? |
| Anesthetics, Local | 2 | 2018 | 205 | 1.16 | Why? |
| Muscle, Skeletal | 5 | 2019 | 915 | 1.15 | Why? |
| Ultrasonography | 7 | 2020 | 4409 | 1.13 | Why? |
| Nerve Block | 2 | 2017 | 183 | 1.08 | Why? |
| Hemiplegia | 3 | 2018 | 38 | 1.07 | Why? |
| Manometry | 3 | 2019 | 91 | 1.04 | Why? |
| Respiratory Aspiration | 2 | 2019 | 23 | 0.98 | Why? |
| Myotonin-Protein Kinase | 2 | 2018 | 16 | 0.94 | Why? |
| Intervertebral Disc Displacement | 2 | 2018 | 25 | 0.92 | Why? |
| Dopamine Agonists | 2 | 2018 | 61 | 0.88 | Why? |
| Median Nerve | 2 | 2017 | 18 | 0.87 | Why? |
| Muscle Contraction | 2 | 2018 | 60 | 0.86 | Why? |
| Rotator Cuff Injuries | 1 | 2020 | 32 | 0.85 | Why? |
| Radionuclide Imaging | 2 | 2018 | 184 | 0.84 | Why? |
| Dystonia | 2 | 2017 | 35 | 0.84 | Why? |
| Clostridium tetani | 1 | 2019 | 9 | 0.82 | Why? |
| Tibial Nerve | 1 | 2019 | 7 | 0.81 | Why? |
| Antiparkinson Agents | 3 | 2017 | 125 | 0.81 | Why? |
| Larynx | 2 | 2018 | 126 | 0.81 | Why? |
| Brachial Plexus Neuropathies | 1 | 2019 | 20 | 0.80 | Why? |
| Sciatic Neuropathy | 1 | 2018 | 4 | 0.78 | Why? |
| Spinal Muscular Atrophies of Childhood | 1 | 2018 | 7 | 0.78 | Why? |
| Trinucleotide Repeat Expansion | 1 | 2018 | 9 | 0.77 | Why? |
| Evoked Potentials, Somatosensory | 1 | 2018 | 40 | 0.77 | Why? |
| Cerebral Palsy | 2 | 2018 | 156 | 0.77 | Why? |
| Venlafaxine Hydrochloride | 1 | 2018 | 30 | 0.76 | Why? |
| Paraparesis, Spastic | 1 | 2018 | 3 | 0.76 | Why? |
| Adrenoleukodystrophy | 1 | 2018 | 3 | 0.76 | Why? |
| Herpes Zoster Oticus | 1 | 2018 | 3 | 0.76 | Why? |
| Tennis Elbow | 1 | 2018 | 6 | 0.76 | Why? |
| Biofeedback, Psychology | 1 | 2018 | 18 | 0.76 | Why? |
| Abdominal Muscles | 1 | 2018 | 26 | 0.75 | Why? |
| Tetanus | 1 | 2019 | 61 | 0.75 | Why? |
| Agnosia | 1 | 2018 | 12 | 0.75 | Why? |
| Massage | 1 | 2019 | 53 | 0.74 | Why? |
| Antidepressive Agents, Second-Generation | 1 | 2018 | 41 | 0.74 | Why? |
| Shoulder | 1 | 2018 | 96 | 0.73 | Why? |
| Verbal Behavior | 1 | 2018 | 26 | 0.73 | Why? |
| Trinucleotide Repeats | 1 | 2017 | 7 | 0.72 | Why? |
| Intervertebral Disc Degeneration | 1 | 2018 | 31 | 0.72 | Why? |
| Lysosomal Storage Diseases | 1 | 2018 | 30 | 0.72 | Why? |
| Triamcinolone | 1 | 2017 | 24 | 0.72 | Why? |
| Nystagmus, Pathologic | 1 | 2018 | 30 | 0.71 | Why? |
| Eye Infections, Bacterial | 1 | 2019 | 86 | 0.71 | Why? |
| Complex Regional Pain Syndromes | 1 | 2017 | 7 | 0.71 | Why? |
| Tremor | 1 | 2018 | 89 | 0.71 | Why? |
| Sialorrhea | 1 | 2017 | 24 | 0.70 | Why? |
| Peripheral Nerve Injuries | 1 | 2019 | 114 | 0.70 | Why? |
| Upper Extremity | 2 | 2018 | 193 | 0.70 | Why? |
| Hospital Planning | 1 | 2020 | 238 | 0.70 | Why? |
| Calcium Channels | 1 | 2018 | 96 | 0.69 | Why? |
| Shoulder Pain | 1 | 2017 | 36 | 0.69 | Why? |
| Deglutition | 2 | 2019 | 104 | 0.69 | Why? |
| Acyclovir | 1 | 2018 | 154 | 0.68 | Why? |
| Thinness | 1 | 2017 | 99 | 0.67 | Why? |
| Ataxia | 1 | 2018 | 133 | 0.66 | Why? |
| Physical and Rehabilitation Medicine | 2 | 2020 | 469 | 0.66 | Why? |
| Lidocaine | 1 | 2018 | 94 | 0.66 | Why? |
| Glycopyrrolate | 1 | 2017 | 51 | 0.65 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.64 | Why? |
| Magnetic Resonance Imaging | 6 | 2018 | 6551 | 0.64 | Why? |
| Neck Pain | 1 | 2018 | 126 | 0.64 | Why? |
| Speech Therapy | 1 | 2018 | 152 | 0.63 | Why? |
| Cranial Nerve Diseases | 1 | 2018 | 148 | 0.63 | Why? |
| Parkinson Disease | 3 | 2017 | 1414 | 0.62 | Why? |
| Spinal Fractures | 1 | 2017 | 124 | 0.62 | Why? |
| Brain Injuries, Traumatic | 2 | 2018 | 381 | 0.61 | Why? |
| Bronchiectasis | 1 | 2020 | 312 | 0.61 | Why? |
| Muscarinic Antagonists | 1 | 2017 | 176 | 0.59 | Why? |
| Lower Extremity | 2 | 2018 | 593 | 0.58 | Why? |
| Rhabdomyolysis | 1 | 2018 | 287 | 0.53 | Why? |
| Republic of Korea | 8 | 2021 | 5858 | 0.53 | Why? |
| Herpes Zoster | 1 | 2019 | 331 | 0.53 | Why? |
| Disease Notification | 1 | 2020 | 639 | 0.53 | Why? |
| Adalimumab | 1 | 2017 | 389 | 0.52 | Why? |
| Hospital Departments | 1 | 2020 | 831 | 0.50 | Why? |
| Radiopharmaceuticals | 1 | 2018 | 763 | 0.50 | Why? |
| Injections | 3 | 2018 | 237 | 0.50 | Why? |
| Spinal Cord Injuries | 1 | 2017 | 270 | 0.50 | Why? |
| Positron-Emission Tomography | 1 | 2018 | 802 | 0.49 | Why? |
| Muscular Diseases | 1 | 2018 | 392 | 0.48 | Why? |
| Pain Measurement | 4 | 2020 | 533 | 0.48 | Why? |
| Exercise Therapy | 2 | 2018 | 976 | 0.48 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.44 | Why? |
| Respiration Disorders | 1 | 2017 | 526 | 0.44 | Why? |
| Drug Overdose | 1 | 2018 | 583 | 0.44 | Why? |
| Pneumothorax | 1 | 2019 | 758 | 0.42 | Why? |
| Cerebrovascular Disorders | 1 | 2018 | 1040 | 0.40 | Why? |
| Body Mass Index | 3 | 2019 | 4306 | 0.39 | Why? |
| Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.39 | Why? |
| Middle Aged | 34 | 2021 | 270681 | 0.37 | Why? |
| Anti-Inflammatory Agents | 2 | 2018 | 6153 | 0.37 | Why? |
| Male | 39 | 2021 | 367725 | 0.37 | Why? |
| Positive-Pressure Respiration | 1 | 2017 | 1160 | 0.36 | Why? |
| Endoscopy | 1 | 2019 | 1564 | 0.36 | Why? |
| Injections, Intra-Articular | 2 | 2018 | 104 | 0.35 | Why? |
| Stroke | 4 | 2019 | 8839 | 0.35 | Why? |
| Fluoroscopy | 2 | 2018 | 140 | 0.35 | Why? |
| Female | 38 | 2021 | 380317 | 0.35 | Why? |
| Retrospective Studies | 19 | 2021 | 105322 | 0.34 | Why? |
| Humans | 58 | 2021 | 930598 | 0.33 | Why? |
| Range of Motion, Articular | 2 | 2017 | 168 | 0.32 | Why? |
| Aged | 25 | 2021 | 215776 | 0.32 | Why? |
| Smoking | 1 | 2019 | 3358 | 0.30 | Why? |
| Saliva | 2 | 2019 | 4679 | 0.29 | Why? |
| Immunoglobulins, Intravenous | 1 | 2017 | 2705 | 0.29 | Why? |
| Glucocorticoids | 2 | 2018 | 4431 | 0.28 | Why? |
| Guillain-Barre Syndrome | 1 | 2017 | 1495 | 0.27 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.27 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.27 | Why? |
| Noninvasive Ventilation | 1 | 2017 | 2329 | 0.26 | Why? |
| Tracheostomy | 1 | 2017 | 1963 | 0.25 | Why? |
| Steroids | 2 | 2020 | 904 | 0.25 | Why? |
| Bronchography | 1 | 2020 | 13 | 0.22 | Why? |
| Nervous System Diseases | 1 | 2020 | 4092 | 0.22 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.22 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.22 | Why? |
| Bronchioles | 1 | 2020 | 33 | 0.22 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.22 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.21 | Why? |
| Logistic Models | 3 | 2021 | 9089 | 0.21 | Why? |
| Postoperative Complications | 1 | 2019 | 5861 | 0.21 | Why? |
| Adult | 19 | 2021 | 244371 | 0.21 | Why? |
| Shoulder Joint | 1 | 2020 | 57 | 0.21 | Why? |
| Tongue | 2 | 2019 | 132 | 0.20 | Why? |
| Sex Factors | 5 | 2021 | 11014 | 0.20 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.20 | Why? |
| Levodopa | 2 | 2017 | 87 | 0.20 | Why? |
| Fund Raising | 1 | 2020 | 35 | 0.20 | Why? |
| Feeding Methods | 1 | 2019 | 15 | 0.20 | Why? |
| Buttocks | 1 | 2019 | 34 | 0.20 | Why? |
| Pressure | 2 | 2019 | 289 | 0.20 | Why? |
| Diagnosis, Differential | 3 | 2019 | 7220 | 0.19 | Why? |
| Pyramidal Tracts | 1 | 2018 | 66 | 0.19 | Why? |
| Treatment Outcome | 7 | 2019 | 51732 | 0.19 | Why? |
| Hip Dislocation | 1 | 2018 | 9 | 0.19 | Why? |
| Age Factors | 5 | 2021 | 21039 | 0.19 | Why? |
| Rupture | 1 | 2018 | 40 | 0.19 | Why? |
| Tropanes | 1 | 2018 | 18 | 0.19 | Why? |
| Basal Ganglia | 1 | 2018 | 49 | 0.18 | Why? |
| Biometry | 1 | 2018 | 69 | 0.18 | Why? |
| Self-Help Devices | 1 | 2018 | 37 | 0.18 | Why? |
| Esophageal Sphincter, Upper | 1 | 2017 | 1 | 0.18 | Why? |
| Trauma, Nervous System | 1 | 2017 | 17 | 0.18 | Why? |
| Methylmalonic Acid | 1 | 2017 | 3 | 0.18 | Why? |
| Diffusion Tensor Imaging | 1 | 2018 | 125 | 0.18 | Why? |
| Sacrum | 1 | 2018 | 41 | 0.18 | Why? |
| Bursitis | 1 | 2018 | 25 | 0.18 | Why? |
| Behavioral Risk Factor Surveillance System | 1 | 2017 | 66 | 0.18 | Why? |
| Gastrostomy | 1 | 2018 | 56 | 0.18 | Why? |
| Spinal Puncture | 1 | 2018 | 95 | 0.18 | Why? |
| Fraud | 1 | 2020 | 116 | 0.18 | Why? |
| Walk Test | 2 | 2018 | 461 | 0.18 | Why? |
| Ulnar Nerve | 1 | 2017 | 12 | 0.17 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.17 | Why? |
| Dopamine | 1 | 2018 | 123 | 0.17 | Why? |
| Frameshift Mutation | 1 | 2018 | 158 | 0.17 | Why? |
| Blood Gas Monitoring, Transcutaneous | 1 | 2017 | 52 | 0.17 | Why? |
| Gait | 1 | 2018 | 137 | 0.17 | Why? |
| Wrist | 1 | 2017 | 37 | 0.17 | Why? |
| Paralysis | 1 | 2018 | 92 | 0.17 | Why? |
| Paresis | 1 | 2018 | 77 | 0.17 | Why? |
| Extremities | 1 | 2018 | 179 | 0.17 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.16 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.16 | Why? |
| Salivary Glands | 1 | 2017 | 122 | 0.16 | Why? |
| Knee Joint | 1 | 2018 | 194 | 0.16 | Why? |
| Fibromyalgia | 1 | 2019 | 174 | 0.16 | Why? |
| Electrodiagnosis | 1 | 2017 | 152 | 0.16 | Why? |
| Neuralgia | 1 | 2017 | 99 | 0.15 | Why? |
| Respiratory Insufficiency | 1 | 2017 | 7301 | 0.15 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.15 | Why? |
| Foot | 1 | 2017 | 195 | 0.15 | Why? |
| Neck | 1 | 2018 | 307 | 0.15 | Why? |
| Sleep Apnea Syndromes | 1 | 2019 | 282 | 0.15 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.15 | Why? |
| Severity of Illness Index | 8 | 2019 | 48226 | 0.15 | Why? |
| Disclosure | 1 | 2020 | 423 | 0.15 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.15 | Why? |
| Action Potentials | 1 | 2017 | 368 | 0.14 | Why? |
| Disability Evaluation | 1 | 2019 | 671 | 0.14 | Why? |
| Fasting | 1 | 2020 | 555 | 0.14 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.14 | Why? |
| Genetic Testing | 1 | 2018 | 395 | 0.14 | Why? |
| Data Accuracy | 1 | 2020 | 715 | 0.14 | Why? |
| Diaphragm | 1 | 2017 | 232 | 0.14 | Why? |
| Prednisolone | 1 | 2017 | 443 | 0.13 | Why? |
| Walking | 1 | 2018 | 442 | 0.13 | Why? |
| Decision Support Systems, Clinical | 1 | 2019 | 551 | 0.13 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.13 | Why? |
| Nebulizers and Vaporizers | 1 | 2017 | 497 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Myasthenia Gravis | 1 | 2019 | 385 | 0.12 | Why? |
| L-Lactate Dehydrogenase | 1 | 2021 | 1995 | 0.12 | Why? |
| Hand | 1 | 2017 | 449 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.12 | Why? |
| Overweight | 1 | 2019 | 916 | 0.12 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.12 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.12 | Why? |
| Video Recording | 1 | 2018 | 786 | 0.12 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.11 | Why? |
| Lung | 1 | 2020 | 31049 | 0.11 | Why? |
| Pain | 1 | 2019 | 1084 | 0.11 | Why? |
| Administration, Inhalation | 1 | 2017 | 1647 | 0.11 | Why? |
| Adrenal Cortex Hormones | 2 | 2018 | 6537 | 0.11 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.10 | Why? |
| Sleep Apnea, Obstructive | 1 | 2019 | 668 | 0.10 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Activities of Daily Living | 1 | 2019 | 1530 | 0.10 | Why? |
| Radiography | 1 | 2018 | 1576 | 0.10 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.10 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.10 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.10 | Why? |
| Patient Positioning | 1 | 2020 | 1505 | 0.09 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.09 | Why? |
| Analgesics, Opioid | 1 | 2019 | 1070 | 0.09 | Why? |
| Cardiomyopathies | 1 | 2018 | 997 | 0.09 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.09 | Why? |
| Heart | 1 | 2018 | 1791 | 0.09 | Why? |
| Crohn Disease | 1 | 2017 | 959 | 0.09 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.09 | Why? |
| Diabetes Complications | 1 | 2020 | 2358 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.08 | Why? |
| Cross-Sectional Studies | 4 | 2018 | 53120 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.08 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.08 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.08 | Why? |
| Blood Glucose | 1 | 2020 | 3642 | 0.08 | Why? |
| Socioeconomic Factors | 2 | 2021 | 8495 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.07 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.07 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.07 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.07 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.07 | Why? |
| Fever | 1 | 2021 | 7795 | 0.07 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.07 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2021 | 8248 | 0.06 | Why? |
| Adolescent | 3 | 2018 | 86841 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2017 | 2580 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Pharyngeal Muscles | 1 | 2019 | 6 | 0.05 | Why? |
| Disease Management | 1 | 2018 | 6841 | 0.05 | Why? |
| Prospective Studies | 3 | 2019 | 43301 | 0.05 | Why? |
| Work Capacity Evaluation | 1 | 2019 | 33 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.05 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.04 | Why? |
| Comorbidity | 2 | 2019 | 34796 | 0.04 | Why? |
| Hand Strength | 1 | 2018 | 202 | 0.04 | Why? |
| Biomechanical Phenomena | 1 | 2018 | 291 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.04 | Why? |
| Polysomnography | 1 | 2019 | 296 | 0.04 | Why? |
| Homocysteine | 1 | 2017 | 83 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2019 | 632 | 0.04 | Why? |
| Vitamin B 12 | 1 | 2017 | 132 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Decision Support Techniques | 1 | 2018 | 903 | 0.03 | Why? |
| United States | 1 | 2017 | 46150 | 0.03 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Fatigue | 1 | 2019 | 2479 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Hospitals, University | 1 | 2018 | 4173 | 0.02 | Why? |
| Health Status | 1 | 2019 | 3259 | 0.02 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |